Search Results

Filter
  • 1-10 of  10,269 results for ""AMYLIN""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Dual amylin and calcitonin receptor agonist treatment reduces biomarkers associated with kidney fibrosis in diabetic rats.

  • Authors : Melander SA; Nordic Bioscience, Herlev, Denmark.; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Subjects: Amylin Receptor Agonists*/Amylin Receptor Agonists*/Amylin Receptor Agonists*/pharmacology ; Amylin Receptor Agonists*/Amylin Receptor Agonists*/Amylin Receptor Agonists*/therapeutic use ; Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/complications

  • Source: American journal of physiology. Endocrinology and metabolism [Am J Physiol Endocrinol Metab] 2023 Nov 01; Vol. 325 (5), pp. E529-E539. Date of Electronic Publication: 2023 Oct 04.Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901226 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight loss.

Subjects: Amylin Receptor Agonists*/Amylin Receptor Agonists*/Amylin Receptor Agonists*/pharmacology ; Bone Density Conservation Agents* ; Diabetes Mellitus, Type 2*

  • Source: European journal of pharmacology [Eur J Pharmacol] 2023 Sep 05; Vol. 954, pp. 175837. Date of Electronic Publication: 2023 Jun 16.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Dual amylin and calcitonin receptor agonist treatment improves insulin sensitivity and increases muscle-specific glucose uptake independent of weight loss.

Subjects: Amylin Receptor Agonists*/Amylin Receptor Agonists*/Amylin Receptor Agonists*/pharmacology ; Insulin Resistance* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Aug; Vol. 164, pp. 114969. Date of Electronic Publication: 2023 Jun 01.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin.

  • Authors : Melander SA; Nordic Bioscience, 2730, Herlev, Denmark. Electronic address: .; Katri A

Subjects: Amylin Receptor Agonists*/Amylin Receptor Agonists*/Amylin Receptor Agonists*/pharmacology ; Amylin Receptor Agonists*/Amylin Receptor Agonists*/Amylin Receptor Agonists*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: European journal of pharmacology [Eur J Pharmacol] 2023 Jan 05; Vol. 938, pp. 175397. Date of Electronic Publication: 2022 Nov 19.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease.

  • Authors : Corrigan RR; School of Biomedical Sciences, Kent State University, Kent, OH, USA.; Labrador L

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/pathology ; Receptors, Islet Amyloid Polypeptide*/Receptors, Islet Amyloid Polypeptide*/Receptors, Islet Amyloid Polypeptide*/antagonists & inhibitors

  • Source: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2023; Vol. 91 (4), pp. 1495-1514.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9814863 Publication Model: Print Cited Medium: Internet ISSN: 1875-8908

Record details

×
Academic Journal

Does receptor balance matter? - Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models.

  • Authors : Larsen AT; Nordic Bioscience, 2730 Herlev, Denmark. Electronic address: .; Mohamed KE

Subjects: Amylin Receptor Agonists*/Amylin Receptor Agonists*/Amylin Receptor Agonists*/pharmacology ; Amylin Receptor Agonists*/Amylin Receptor Agonists*/Amylin Receptor Agonists*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Dec; Vol. 156, pp. 113842. Date of Electronic Publication: 2022 Oct 12.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Design, synthesis and preclinical evaluation of bio-conjugated amylinomimetic peptides as long-acting amylin receptor agonists.

  • Authors : Patch RJ; Janssen Research & Development, LLC, Welsh and McKean Roads, Spring House, PA 19477, USA. Electronic address: .; Zhang R

Subjects: Amylin Receptor Agonists*/Amylin Receptor Agonists*/Amylin Receptor Agonists*/pharmacology ; Amylin Receptor Agonists*/Amylin Receptor Agonists*/Amylin Receptor Agonists*/therapeutic use; Amyloid

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2022 Jun 05; Vol. 236, pp. 114330. Date of Electronic Publication: 2022 Apr 04.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Safety, tolerability and pharmacokinetic characterisation of DACRA KBP-042 in healthy male subjects.

  • Authors : Henriksen K; Nordic Bioscience, Herlev, Denmark.; KeyBioscience AG, Stans, Switzerland.

Subjects: Amylin Receptor Agonists*/Amylin Receptor Agonists*/Amylin Receptor Agonists*/pharmacology; Calcitonin/Calcitonin/Calcitonin/analogs & derivatives ; Dose-Response Relationship, Drug

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Dec; Vol. 87 (12), pp. 4786-4796. Date of Electronic Publication: 2021 Jun 18.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

KBP-066A, a long-acting dual amylin and calcitonin receptor agonist, induces weight loss and improves glycemic control in obese and diabetic rats.

Subjects: Amylin Receptor Agonists/Amylin Receptor Agonists/Amylin Receptor Agonists/*pharmacology ; Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/*drug therapy ; Obesity/Obesity/Obesity/*drug therapy

  • Source: Molecular metabolism [Mol Metab] 2021 Nov; Vol. 53, pp. 101282. Date of Electronic Publication: 2021 Jun 29.Publisher: Elsevier GmbH Country of Publication: Germany NLM ID: 101605730 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  10,269 results for ""AMYLIN""